Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Easier-To-Clean Duodenoscope Gets US FDA Clearance

Executive Summary

The device from Pentax features a disposable distal cap, thus cutting the risk of infection transmission between patients. An earlier Pentax duodenoscope model was the subject of an infection-related safety alert in January.

You may also be interested in...



New Duodenoscope Protocols Released

US FDA, CDC and medical groups joined forces to develop safer handling standards for the endoscope equipment, which has been tied to infection outbreaks.

Cracks, Gaps In Pentax Duodenoscopes Prompt Company, US FDA Safety Communications

Pentax Corp. sent out a field correction on Jan. 16, and FDA followed up with a safety communication the next day, warning that cracks and gaps in the company's ED-3490TK duodenosopes could increase risks of patient microbial infections, unless appropriate reprocessing instructions are followed closely.

FDA Advisors Call For New Cleaning Methods, Sterilization For Duodenoscopes

Current reprocessing methods for duodenoscopes provide no reasonable assurance of safety and effectiveness, and manual cleaning steps need improvement, an FDA panel said. Most panelists called for upgrading manual cleaning, followed by lengthy sterilization of the products until they can be redesigned.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121516

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel